AbbVie
ABBV
#25
Rank
HK$4.060 T
Marketcap
HK$2,297
Share price
-0.59%
Change (1 day)
26.29%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): HK$100.34 Billion

According to AbbVie's latest financial reports the company's current earnings are HK$66.01 Billion. In 2025 the company made an earning of HK$51.75 Billion, an increase over its 2024 earnings that were of HK$29.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$100.34 B93.88%
2025 HK$51.75 B77.53%
2024 HK$29.15 B-40.54%
2023 HK$49.03 B-53.62%
2022 HK$105.73 B3.76%
2021 HK$101.90 B282.25%
2020 HK$26.65 B-59.67%
2019 HK$66.10 B62.13%
2018 HK$40.77 B-32.74%
2017 HK$60.62 B-1.99%
2016 HK$61.85 B18.65%
2015 HK$52.13 B180.5%
2014 HK$18.58 B-55.57%
2013 HK$41.83 B-6.86%
2012 HK$44.91 B56.05%
2011 HK$28.78 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.66 B-45.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$272.77 B 171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$86.70 B-13.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$3.49 B-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$19.88 Billion-119.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$88.90 B-11.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$118.37 B 17.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$56.12 B-44.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$6.77 B-93.27%๐Ÿ‡บ๐Ÿ‡ธ USA